Plandai Biotechnology Inc (PLPL)

[Tonyeight]

SOUTH AFRICA’S FIGHT FOR LEGALISATION (PART 1)

HOME / EDUCATION / SOUTH AFRICA’S FIGHT FOR LEGALISATION (PART 1)
South Africa’s fight for legalisation (Part 1)
SOUTH AFRICA’S FIGHT FOR LEGALISATION (PART 1)
By i420CPT Editor Posted 28/06/2016 In Education, Health, Legal, Lifestyle, Waaf's New 1 1
The fight for dagga legalisation is taking the wrong direction. The South African Cannabis Community and Regulatory Association explains why.

SACCRA COMMENTARY ON THE CURRENT CANNABIS LEGALISATION CONUNDRUM

PART 1: THE SET-UP FOR WORLDWIDE MONOPOLY

Plandai Biotechnology, Inc. Petitions South Africa Department of Health for License to Conduct Cannabis Research

The current legal action in South Africa was initiated by Plandai Biotechnology, a privately owned company of U.S. investors based in Seattle, America, who own a farm called Senteeko in Mpumalanga, South Africa.

They were granted loans from the Department of Trade and Industries and the SA Land Bank (R100 Million) in 2014, and propose to use their patented “delivery system” combined with “cannabinoids” in pharmaceutical preparations. This company negotiated with the Director General of the Dept. of Health, the Dept. of Trade and Industries and other government agencies and parties to amend certain laws in 2014 and since, to pave the way for the implementation of the Bill.


Plandai Biotechnology Management Discusses Progress of Company's Cannabis Extracts
NEW YORK, NY--(Marketwired - Mar 28, 2014) - Last month Plandaí Biotechnology, Inc. (OTCQB: PLPL) closed a licensing agreement with Diego Pellicer, Inc. that will allow the company to use the Diego Pellicer name for its Phytofare™ cannabis extract in medical and pharmaceutical marijuana applications. Plandaí will produce the new Diego Pellicer Gold™ extracts in both capsules and cannabis oil (for vapor use) in Pheroid™ and non-Pheroid™ versions to appeal to the broadest range of medicinal consumers.

http://www.marketwired.com/press-release/plandai-biotechnology-management-discusses-progress-of-companys-cannabis-extracts-otcqb-plpl-1893567.htm













“SEATTLE, WA–(Marketwired – Apr 28, 2014) – Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced it has filed a petition with the Attorney General from the South African Department of Health to obtain a license permitting the company to commence clinical research on the therapeutic and medicinal benefits of cannabis. The petition was made pursuant to Section 22A (9) of the Medicines and Related Substances Act No. 101 of 1965, which provides for pharmaceutical research with cannabis.”

The list of directors includes:

Jamen Shively: Vice President of Marketing for Plandaí, former executive of Microsoft
Vincente Fox: former Mexican president
Douglas Anderson: fundraising – former Ponzi scheme operator
Ron Throgmartin: CEO Diego Pellicer Worldwide
Peter Norris: CEO
John B. Davis: CEO Northwest Patient Resource Center
Daniela Bernhard: Founder, Partner, and General Manager of Northwest Patient Resource Center
Jake Dimmock: Partner and Cannabis Quality Assurance Manager for Northwest Patient Resource Center

Jamen Shively, a former Microsoft corporate strategy manager, said he envisions his Seattle-based enterprise becoming the leader in both recreational and medical cannabis – much like Starbucks is the dominant name in coffee.

The Medical Innovations Bill currently under review in Parliament seeks to legalise “cannabinoids” (not Cannabis) for beneficial medicinal, commercial and industrial use under a single license.

The only amendment sought to the Drugs and Drug Trafficking Act, which was done in 2014, included any and all preparations containing cannabinoids under this act as well as the Medicines Act Schedules.

“Plandaí’s live-plant extraction process recovers phytonutrients from plant material in a mainly nano particle form and rearranges the antioxidants (polyenes) into a format bio-compatible with humans and animals. In addition, through Plandaí’s agreement with North West University, South Africa, the company holds the world license to the Pheroid® patented entrapment system to deliver protected Phytofare™ antioxidants to the white blood cells.”

It is now common knowledge that all the medicine of cannabis is perfectly bio-available in raw form in the mature flowers of the plant, which can be eaten, juiced, smoked or cooked into food.

It is now also common knowledge that this medicine is moreover perfectly easy to extract in a domestic setting for the minimal cost of the carrier oil where you grow your own plants. These plants are perfectly suited to thrive in South African conditions with barely any supervision or attention. If we so choose, of course…

Then, the Medicines & Related Substances Act was amended and signed by the president on 24/12/2015 to include all substances which affect human and animal health, even in a preventative manner, under the control of the old Medicines Control Council whose power has now been expanded to include all natural and traditional remedies (S.A.H.P.R.A.).

The Central Drug Authority, the Medicines Control Council and the Medical Research Council (all accountable to the Dept. of Health) have provided position papers to the Parliamentary Committee on Health who are processing the Medical Innovations Bill. All of these reports are drastically skewed and present minimal, dated evidence which perpetuate the scientifically incorrect view that cannabis is a dangerous drug, but which acknowledge that it “may” have some, limited medicinal properties that must be further researched.

From the beginning, the reference to legalising cannabis or marijuana has been used, in a most deceptive manner, in all press releases. Recently the ANC and IFP announced that they would seek to “decriminalise” cannabis in South Africa, once again playing on our ignorance of what that term actually means. The proposed change will do nothing about removing cannabis from criminal law, but will rather mean that the police will be instructed to “turn a blind eye” to small amounts for personal consumption.

The illegal criminal market will continue undisturbed, but responsible citizens will not be allowed to trade in plants or plant matter, make or trade in natural extracts, or use the plant for industrial purposes, unless they manage to obtain licenses which cost in the region of half a million rand. We will still be treated like criminals and most likely with maximum penalties being applied.

So, although this is made to sound like a step forward, it actually only placates Cannabis users into accepting the monopolisation of the plant.

Plandai Biotechnology, via Advocate Stransham-Ford approached the traditional leaders in 2014 to negotiate deals for growing Cannabis in the sovereign lands of South Africa, where for decades, peoples’ crops have been destroyed and sprayed by the SAPS Air Wing Unit. These deals were concluded.

Plandai Biotechnology has to operate under license to the U.S. government who have owned the “worldwide patent on cannabinoids” since 2003. Now, although this is unnatural, unconstitutional and a violation of every civil liberty known to man, they have legislated this into effect worldwide through International treaties such as the UNSCND.

Even if cannabis is eventually made available to South Africans in smoked form, you will have to pay a manipulated and controlled price for what you can grow for free. This company, and to a lesser extent its subsidiary licensees, will be the sole beneficiary of all proceeds of the Cannabis industry in South Africa.